share_log

佳兆業集團:清盤呈請聆訊延期

KAISA GROUP: ADJOURNMENT OF THE WINDING-UP PETITION HEARING

香港交易所 ·  Mar 7 23:19
Summary by Moomoo AI
佳兆業集團控股有限公司(「本公司」)於2024年3月8日宣布,高等法院已批准花旗國際有限公司(「替代呈請人」)替代為呈請人,並允許提交及送達針對本公司的重新修訂呈請書。該呈請書涉及本公司於2023年到期的10.875%票據未償還本金750,000,000美元及應計利息。重新修訂呈請的聆訊已延期至2024年4月29日,而有關原呈請的撤銷申請已經被駁回。本公司提醒證券持有人及潛在投資者在買賣本公司證券時應審慎行事。
佳兆業集團控股有限公司(「本公司」)於2024年3月8日宣布,高等法院已批准花旗國際有限公司(「替代呈請人」)替代為呈請人,並允許提交及送達針對本公司的重新修訂呈請書。該呈請書涉及本公司於2023年到期的10.875%票據未償還本金750,000,000美元及應計利息。重新修訂呈請的聆訊已延期至2024年4月29日,而有關原呈請的撤銷申請已經被駁回。本公司提醒證券持有人及潛在投資者在買賣本公司證券時應審慎行事。
JiaZhaoyi Group Holdings Limited (the “Company”) announced on 8 March 2024 that the High Court has approved Citibank International Limited (the “Alternate Petitioner”) as the Petitioner to replace it and to allow the submission and delivery of the Petition for Revision against the Company. The Petition involves $750 million in outstanding principal and accrued interest on the Company's 10.875% Notes due 2023. The hearing on the revised petition has been adjourned until 29 April 2024, and the application for withdrawal of the original petition has been rejected. The Company reminds security holders and potential investors to exercise caution when buying and selling the Company's securities.
JiaZhaoyi Group Holdings Limited (the “Company”) announced on 8 March 2024 that the High Court has approved Citibank International Limited (the “Alternate Petitioner”) as the Petitioner to replace it and to allow the submission and delivery of the Petition for Revision against the Company. The Petition involves $750 million in outstanding principal and accrued interest on the Company's 10.875% Notes due 2023. The hearing on the revised petition has been adjourned until 29 April 2024, and the application for withdrawal of the original petition has been rejected. The Company reminds security holders and potential investors to exercise caution when buying and selling the Company's securities.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more